A Rare Case of Dual Metachronous Primary Malignancies, Chronic Myeloid Leukemia, and Tongue Carcinoma in a Patient With Long-Standing Systemic Lupus Erythematosus: A Case Report and Review of Literature

• Published in: Cureus 2024, Vol.16 (3), p.e56648-e56648
• Main Authors: BalajiSubramanian, Sitaraman, Al-Hajri, Thuraya, Satyapal, Namrata, Al-Bulushi, Mahdiya, Al Sheibani, Salma Mohammed, Al Kalbani, Faisal Khamis Mubarak, Al-Saadi, Maimuna, Al Musalhi, Muhanna Nasser, Al Wahshi, Humaid A
• Format: Report
• Language: English
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.56648

Patients with long-standing autoimmune diseases like systemic lupus erythematosus (SLE) are at a higher risk of developing hematological malignancies. However, chronic myeloid leukemia (CML) has rarely been reported in patients with SLE. Advancements in medical diagnostics and treatment have led to the life expectancy of SLE and CML patients moving closer to that of the general population, and it is not uncommon to encounter more than one malignancy in a cancer survivor. Although squamous cell carcinoma (SCC) of the skin has been reported in CML patients, mucosal SCC of the head and neck has rarely only been reported in CML survivors. The objective of this case report is to share our experience in treating a patient with dual metachronous primary malignancies, CML, and tongue carcinoma, along with long-standing SLE, managed by a multidisciplinary team.